All Categories
History
Price (excluding tax)
Response Rate
100.0%
Response Time
88.9hours
Nucleofector™ kits and corresponding optimization protocols are available on a variety of Nucleofector™ platforms for optimal gene transfer into human pulmonary microvascular endothelial cells. The kit of choice for transfecting human lung microvascular endothelial cells in the 4D-Nucleofector™, 96-well Shuttle™ and 384-well Nucleofector™ systems is the P5 Primary Cell Kit. Use in conjunction with the Mammalian Endothelial Cell Basic Protocol. The Nucleofector™II/2b device uses a human lung microvascular endothelial cell specific kit. ■Advantages ・Gene transfer efficiency: up to 79% ・Survival rate: up to 52% ・High gene transfer efficiency into human pulmonary microvascular endothelial cells without using viruses ■Applications Clonetics™ confirmed in human lung microvascular endothelial cells
You can search for other models from each index. The displayed value is the value of the currently selected part number.
See all 4 models in listPart Number
Nucleofector™ Kit for Human Lung Microvascular Endothelial Cells (HMVEC-L)Handling Company
Lonza Co., Ltd.| Image | Price (excluding tax) |
|---|---|
|
|
Available upon quote |
Reviews shown here are reviews of companies.
Response Rate
100.0%
Response Time
88.9hrs
